Article
Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression.
Blood - 1 Mar 2004
Zheng Rui, Friedman Alan D, Levis Mark, Li Li, Weir Edward G, Small Donald
Abstract excerpt
Constitutively activating mutations of FMS-like tyrosine kinase 3 (FLT3) occur in approximately one third of patients with acute myeloid leukemia (AML) and are associated with poor prognosis. Altered FLT3 signaling leads to antiapoptotic and proliferative signaling pathways. We recently showed that these mutations can also contribute to the differentiation arrest that characterizes leukemia. In this report we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
